## **Trustees’ Annual Report for the period** **From 01.01.2024 Period start date To 31.12.2024 Period end date Charity name: UK Acute Oncology Society** ## **Charity registration number: 1199351** ## **Objectives and Activities** ||SORP reference|| |---|---|---| |Summary of the purposes of
the charity as set out in its
governing document|Para 1.17|•For the public benefit, to advance the
education of all healthcare professionals
involved in treating or supporting patients
in the field of acute oncology.
•In furtherance of the object above, to
promote research for the public benefit in
all aspects of that subject and to publish
the useful results.
•The relief of sickness and preservation of
health, from cancer, among people
residing permanently or temporarily in the
UK.
•To assist in the treatment and care of
persons suffering from cancer, or in need
of rehabilitation, by the provision of
education for healthcare professionals.
•To promote the wellbeing of people
suffering from acute effects of cancer
and/or anti-cancer treatment and support
the development of acute oncology
services in the UK through assisting in
the provision of education.| |Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or
services identified in the
accounts.|Para 1.17 and
1.19|1. Provision of forum for Health Care
professionals
supporting
emergency
cancer care.
2. Annual educational programme.
3. Website and educational resources.
4. Supporting service innovation, shared
learning and research promotion.| |Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit|Para 1.18|The UKAOS trustees have had regard to the
guidance issued by the Charity Commission
on public benefit.| **Additional information (optional)** You may choose to include further statements where relevant about: SORP reference Para 1.38 Policy on grant making Para 1.38 Policy on social investment including program related investment Para 1.38 Contribution made by volunteers Other ## **Achievements and Performance** ||SORP reference|| |---|---|---| |Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.|Para 1.20|**Ongoing UKAOS Governance Review**
The UKAOS initiated a Trustee rotation as
per the constitution with 3 new Trustees
appointed and 2 Trustee farewells.
As part of a wider Governance review, a
newly established Programme Management
Group (Nov 23) conducted a review of
UKAOS Subgroups with refreshed Terms of
Reference and several significant changes
in line with the evolving UKAOS priorities
including:
Closure of the trainee subgroup (in favour of
integrating trainees across all groups).
Closure
of
the
Radiotherapy
Toxicity
subgroup (in favour of an amalgamated
approach to Treatment Toxicity).
Launch of 3 new Subgroups: Nursing,
Malignancy of Unknown origin (MUO) and
Metastatic
Spinal
Cord
Compression
(MSCC)
–
each
recognising
national
leadership in these areas from UKAOS.
**UKAOS Influence**
Development and stakeholder engagement
of the first UKAOS 5-year Strategy (2025-
2030) – subsequently published 2025.| |UKAOS engagement with NHS England| |---| |successfully delivering Oncology as a core| |component
of
national
Same
Day| |Emergency Care (SDEC) Strategy.| |4 Nation Cancer Hotline Review – national| |survey and analysis 2024.| |Formal agreement for UKAOS clinical| |representation
at
national
bodies| |(Association of Cancer Physicians, Royal| |College of Radiologists).| |First national Acute Oncology Week 7-11th| |Oct 24.| |UKAOS Board member awarded MBE.| |Successful Launch of first ever Nepal Acute| |Oncology Service Model with UKAOS| |support.| |**UKAOS Education & Training**| |Successful delivery of a national 1-day| |UKAOS Conference (Sept 24).| |Co Chairmanship and launch of National| |Acute Oncology Education Group.| |Successful sessional delivery of UKAOS at| |national conferences (UK Oncology Forum| |June 24, UK SACT Board Nov 24), Society| |of Acute Medicine AO Webinar Dec 24.| |UKAOS agreement to deliver monthly online| |learning hour through 2025.| ## **Additional information (optional)** You may choose to include further statements where relevant about: |Achievements against
objectives set|Para 1.41|| |---|---|---| |Performance of fundraising
activities against objectives
set|Para 1.41|| |Investment performance
against objectives|Para 1.41|| Other ## **Financial Review** |**Financial Review**||| |---|---|---| |Review of the charity’s
financial position at the end
of the period|Para 1.21|Details of receipts and payments are given
in the Receipts and Payments Account
within the financial statements. The total
unrestricted funds as at 31 December 2024
amounted to £4,755 (2023: £20,074)| |Statement explaining the
policy for holding reserves
stating why they are held|Para 1.22|To fund future projects.| |Amount of reserves held|Para 1.22|The free reserves at 31 December 2024 are
£4,755 (2023: £14,074) and the trustees are
satisfied that this level of reserves is
sufficient to meet the needs of the charity in
its early stages of development.| |Reasons for holding zero
reserves|Para 1.22|Not applicable.| |Details of fund materially in
deficit|Para 1.24|None.| |Explanation of any
uncertainties about the
charity continuing as a going
concern|Para 1.23|There are no uncertainties about the charity
continuing as a going concern.| ## **Additional information (optional)** You may choose to include further statements where relevant about: |||| |---|---|---| |The charity’s principal
sources of funds (including
any fundraising)|Para 1.47|| |Investment policy and
objectives including any
social investment policy
adopted|Para 1.46|| |A description of the principal
risks facing the charity|Para 1.46|| |Other||| ## **Structure, Governance and Management** |Description of charity’s
trusts:||| |---|---|---| |Type of governing document
(trust deed, royal charter)|Para 1.25|Constitution.| |How is the charity
constituted?
(e.g unincorporated
association, CIO)|Para 1.25|Charitable Incorporated Organisation (CIO)| |Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees|Para 1.25|Election by UKAOS members at Annual
General Meeting.| ## **Additional information (optional)** You may choose to include further statements where relevant about: Policies and procedures adopted for the induction Para 1.51 and training of trustees The charity’s organisational structure and any wider Para 1.51 network with which the charity works Relationship with any related Para 1.51 parties Other ## **Reference and Administrative details** |Charity name|UK Acute Oncology Society| |---|---| |Other name the charity uses|UKAOS| |Registered charity number|1199351| |Charity’s principal address|UKAOS Secretariat
c/o Media1 Productions Ltd
Clarence Mill, Clarence Road
Bollington
Macclesfield
SK10 5JZ| ||| **Names of the charity trustees who manage the charity** **Trustee name Office (if any)** **Dates acted if not for whole year** **Name of person (or body) entitled to appoint trustee (if any)** |1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20|Dr E Marshall|Chair||| |---|---|---|---|---| ||Dr C Mitchell||Upto 1.9.24|| ||Dr H J Williams|Treasurer||| ||P J Jones|||| ||N R Clatworthy||Upto 1.9.24|| ||Dr C Wilson|Secretary||| ||J Upton||From 1.9.24|| ||D Munro||From 1.9.24|| ||P Gillis||From 1.9.24|| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| ## – Corporate trustees names of the directors at the date the report was approved **Director name** Name of trustees holding title to property belonging to the charity **Trustee name Dates acted if not for whole year** ## **Funds held as custodian trustees on behalf of others** Description of the assets None. held in this capacity Name and objects of the Not applicable. charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for Not applicable. safe custody and segregation of such assets from the charity’s own assets ## **Additional information (optional)** ## **Names and addresses of advisers (Optional information)** **Type of Name Address adviser** **Name of chief executive or names of senior staff members (Optional information)** ## **Exemptions from disclosure** Reason for non-disclosure of key personnel details Not applicable. ## **Other optional information** Not applicable ## **Declarations** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** **Signature(s) Full name(s)** Dr ERNEST MARSHALL **Position (eg Secretary, Chair, etc)** Chair **Date** 24/10/2025 ||**UK Acute Oncology Society (UKAOS)**
**Charity Name**|**UK Acute Oncology Society (UKAOS)**
**Charity Name**|**UK Acute Oncology Society (UKAOS)**
**Charity Name**|**1199351**
**No (if any)**|**1199351**
**No (if any)**|**1199351**
**No (if any)**|**CC16a**| |---|---|---|---|---|---|---|---| ||**For the period**
**from**|01-Jan-24
Period start date|**To**||31-Dec-24
Period end date||| ||||||||| |**Section A Receipts and payments**|||||||| |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest £**
**14,000**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**14,000**
**4,800**
**-**
**4,800**
**18,800**
**265**
**848**
**21,306**
**900**
**10,800**
**-**
**-**
**-**
**-**
**34,119**
**-**
**-**
**-**
**34,119**
**- 15,319**
**-**
**20,074**
**4,755**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**||**Total funds**
**to the nearest £**
**14,000**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**14,000**
**4,800**
**-**
**4,800**
**18,800**
**265**
**848**
**21,306**
**900**
**10,800**
**-**
**-**
**-**
**-**
**34,119**
**-**
**-**
**-**
**34,119**
**- 15,319**||**Last year**
**to the nearest £**| |Sponsorships and grants|**14,000**||||||**20,000**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| |**_Sub total_**_(Gross income for_
_AR)_|**14,000**||||||**20,000**| ||||||||| ||||||||| |Fundsreceivedinerror|**4,800**||||||**6,000**| ||**-**||||||**-**| |**_Sub total_**|**4,800**||||||**6,000**| |**_Total receipts_ **
**A3 Payments**|||||||| ||||||||**26,000**| ||||||||| |
Bank charges|**265**||||||**300**| |
Website expenses|**848**||||||**2,058**| |
Secretariat|**21,306**||||||**7,162 **| |Accountancy|**900**||||||**900**| |Repayment for funds received in
error|**10,800**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| |**_Sub total_ **|**34,119**||||||**10,420**| ||||||||| |**A4 Asset and investment**
**purchases (see table)**|||||||| |**,**|**-**||||||| ||**-**||||||| |**_Sub total_ **|**-**||||||**-**| |**_Total payments_ **
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**|||||||| ||||||||**10,420**| ||||||||| ||**- 15,319**|**-**|**-**||**- 15,319**||**15,580**| ||**-**|**-**|**-**||**-**||**-**| ||**20,074**|**-**|**-**||**20,074**||**4,494**| ||**4,755**|**-**|**-**||**4,755**||**20,074**| CCXX R1 accounts (SS) 20/10/2025 1 |**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|| |---|---|---|---| |**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B1 Cash funds**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B5 Liabilities**
**B3 Investment assets**|Signature
**Details**
Bank
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**
**Details**
**Details**|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**4,755**
**-**
**-**
**-**
**-**
**-**
**4,755**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
Print Name
E MARSHALL|**Endowment**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**When due**
**(optional)**| ||||| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| |||E MARSHALL|24/10/2025| ||||| CCXX R2 accounts (SS) 20/10/2025 2